Toll Free: 1-888-928-9744
Published: Oct, 2018 | Pages:
93 | Publisher: QYResearch
Industry: Healthcare | Report Format: Electronic (PDF)
In 2017, the global Glioblastoma Multiforme Treatment market size was million US$ and it is expected to reach million US$ by the end of 2025, with a CAGR of during 2018-2025. This report focuses on the global Glioblastoma Multiforme Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Glioblastoma Multiforme Treatment development in United States, Europe and China. The key players covered in this study AbbVie, Inc Activartis GmbH Agenus Inc Arog Pharmaceuticals, Inc Bristol-Myers Squibb Company Cavion LLC Celldex Therapeutics Inc Cortice Biosciences Exelixis Inc F. Hoffmann-La Roche Ltd. Market segment by Type, the product can be split into Bevacizumab (Avastin) Carmustine (BiCNU) Temozolomide (Temodar and Temodal and Temcad) Market segment by Application, split into Hospital Clinic Others Market segment by Regions/Countries, this report covers United States Europe China Japan Southeast Asia India Central & South America The study objectives of this report are: To analyze global Glioblastoma Multiforme Treatment status, future forecast, growth opportunity, key market and key players. To present the Glioblastoma Multiforme Treatment development in United States, Europe and China. To strategically profile the key players and comprehensively analyze their development plan and strategies. To define, describe and forecast the market by product type, market and key regions. In this study, the years considered to estimate the market size of Glioblastoma Multiforme Treatment are as follows: History Year: 2013-2017 Base Year: 2017 Estimated Year: 2018 Forecast Year 2018 to 2025 For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents 1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered 1.4 Market Analysis by Type 1.4.1 Global Glioblastoma Multiforme Treatment Market Size Growth Rate by Type (2013-2025) 1.4.2 Bevacizumab (Avastin) 1.4.3 Carmustine (BiCNU) 1.4.4 Temozolomide (Temodar and Temodal and Temcad) 1.5 Market by Application 1.5.1 Global Glioblastoma Multiforme Treatment Market Share by Application (2013-2025) 1.5.2 Hospital 1.5.3 Clinic 1.5.4 Others 1.6 Study Objectives 1.7 Years Considered 2 Global Growth Trends 2.1 Glioblastoma Multiforme Treatment Market Size 2.2 Glioblastoma Multiforme Treatment Growth Trends by Regions 2.2.1 Glioblastoma Multiforme Treatment Market Size by Regions (2013-2025) 2.2.2 Glioblastoma Multiforme Treatment Market Share by Regions (2013-2018) 2.3 Industry Trends 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Opportunities 3 Market Share by Key Players 3.1 Glioblastoma Multiforme Treatment Market Size by Manufacturers 3.1.1 Global Glioblastoma Multiforme Treatment Revenue by Manufacturers (2013-2018) 3.1.2 Global Glioblastoma Multiforme Treatment Revenue Market Share by Manufacturers (2013-2018) 3.1.3 Global Glioblastoma Multiforme Treatment Market Concentration Ratio (CR5 and HHI) 3.2 Glioblastoma Multiforme Treatment Key Players Head office and Area Served 3.3 Key Players Glioblastoma Multiforme Treatment Product/Solution/Service 3.4 Date of Enter into Glioblastoma Multiforme Treatment Market 3.5 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type and Application 4.1 Global Glioblastoma Multiforme Treatment Market Size by Type (2013-2018) 4.2 Global Glioblastoma Multiforme Treatment Market Size by Application (2013-2018) 5 United States 5.1 United States Glioblastoma Multiforme Treatment Market Size (2013-2018) 5.2 Glioblastoma Multiforme Treatment Key Players in United States 5.3 United States Glioblastoma Multiforme Treatment Market Size by Type 5.4 United States Glioblastoma Multiforme Treatment Market Size by Application 6 Europe 6.1 Europe Glioblastoma Multiforme Treatment Market Size (2013-2018) 6.2 Glioblastoma Multiforme Treatment Key Players in Europe 6.3 Europe Glioblastoma Multiforme Treatment Market Size by Type 6.4 Europe Glioblastoma Multiforme Treatment Market Size by Application 7 China 7.1 China Glioblastoma Multiforme Treatment Market Size (2013-2018) 7.2 Glioblastoma Multiforme Treatment Key Players in China 7.3 China Glioblastoma Multiforme Treatment Market Size by Type 7.4 China Glioblastoma Multiforme Treatment Market Size by Application 8 Japan 8.1 Japan Glioblastoma Multiforme Treatment Market Size (2013-2018) 8.2 Glioblastoma Multiforme Treatment Key Players in Japan 8.3 Japan Glioblastoma Multiforme Treatment Market Size by Type 8.4 Japan Glioblastoma Multiforme Treatment Market Size by Application 9 Southeast Asia 9.1 Southeast Asia Glioblastoma Multiforme Treatment Market Size (2013-2018) 9.2 Glioblastoma Multiforme Treatment Key Players in Southeast Asia 9.3 Southeast Asia Glioblastoma Multiforme Treatment Market Size by Type 9.4 Southeast Asia Glioblastoma Multiforme Treatment Market Size by Application 10 India 10.1 India Glioblastoma Multiforme Treatment Market Size (2013-2018) 10.2 Glioblastoma Multiforme Treatment Key Players in India 10.3 India Glioblastoma Multiforme Treatment Market Size by Type 10.4 India Glioblastoma Multiforme Treatment Market Size by Application 11 Central & South America 11.1 Central & South America Glioblastoma Multiforme Treatment Market Size (2013-2018) 11.2 Glioblastoma Multiforme Treatment Key Players in Central & South America 11.3 Central & South America Glioblastoma Multiforme Treatment Market Size by Type 11.4 Central & South America Glioblastoma Multiforme Treatment Market Size by Application 12 International Players Profiles 12.1 AbbVie, Inc 12.1.1 AbbVie, Inc Company Details 12.1.2 Company Description and Business Overview 12.1.3 Glioblastoma Multiforme Treatment Introduction 12.1.4 AbbVie, Inc Revenue in Glioblastoma Multiforme Treatment Business (2013-2018) 12.1.5 AbbVie, Inc Recent Development 12.2 Activartis GmbH 12.2.1 Activartis GmbH Company Details 12.2.2 Company Description and Business Overview 12.2.3 Glioblastoma Multiforme Treatment Introduction 12.2.4 Activartis GmbH Revenue in Glioblastoma Multiforme Treatment Business (2013-2018) 12.2.5 Activartis GmbH Recent Development 12.3 Agenus Inc 12.3.1 Agenus Inc Company Details 12.3.2 Company Description and Business Overview 12.3.3 Glioblastoma Multiforme Treatment Introduction 12.3.4 Agenus Inc Revenue in Glioblastoma Multiforme Treatment Business (2013-2018) 12.3.5 Agenus Inc Recent Development 12.4 Arog Pharmaceuticals, Inc 12.4.1 Arog Pharmaceuticals, Inc Company Details 12.4.2 Company Description and Business Overview 12.4.3 Glioblastoma Multiforme Treatment Introduction 12.4.4 Arog Pharmaceuticals, Inc Revenue in Glioblastoma Multiforme Treatment Business (2013-2018) 12.4.5 Arog Pharmaceuticals, Inc Recent Development 12.5 Bristol-Myers Squibb Company 12.5.1 Bristol-Myers Squibb Company Company Details 12.5.2 Company Description and Business Overview 12.5.3 Glioblastoma Multiforme Treatment Introduction 12.5.4 Bristol-Myers Squibb Company Revenue in Glioblastoma Multiforme Treatment Business (2013-2018) 12.5.5 Bristol-Myers Squibb Company Recent Development 12.6 Cavion LLC 12.6.1 Cavion LLC Company Details 12.6.2 Company Description and Business Overview 12.6.3 Glioblastoma Multiforme Treatment Introduction 12.6.4 Cavion LLC Revenue in Glioblastoma Multiforme Treatment Business (2013-2018) 12.6.5 Cavion LLC Recent Development 12.7 Celldex Therapeutics Inc 12.7.1 Celldex Therapeutics Inc Company Details 12.7.2 Company Description and Business Overview 12.7.3 Glioblastoma Multiforme Treatment Introduction 12.7.4 Celldex Therapeutics Inc Revenue in Glioblastoma Multiforme Treatment Business (2013-2018) 12.7.5 Celldex Therapeutics Inc Recent Development 12.8 Cortice Biosciences 12.8.1 Cortice Biosciences Company Details 12.8.2 Company Description and Business Overview 12.8.3 Glioblastoma Multiforme Treatment Introduction 12.8.4 Cortice Biosciences Revenue in Glioblastoma Multiforme Treatment Business (2013-2018) 12.8.5 Cortice Biosciences Recent Development 12.9 Exelixis Inc 12.9.1 Exelixis Inc Company Details 12.9.2 Company Description and Business Overview 12.9.3 Glioblastoma Multiforme Treatment Introduction 12.9.4 Exelixis Inc Revenue in Glioblastoma Multiforme Treatment Business (2013-2018) 12.9.5 Exelixis Inc Recent Development 12.10 F. Hoffmann-La Roche Ltd. 12.10.1 F. Hoffmann-La Roche Ltd. Company Details 12.10.2 Company Description and Business Overview 12.10.3 Glioblastoma Multiforme Treatment Introduction 12.10.4 F. Hoffmann-La Roche Ltd. Revenue in Glioblastoma Multiforme Treatment Business (2013-2018) 12.10.5 F. Hoffmann-La Roche Ltd. Recent Development 13 Market Forecast 2018-2025 13.1 Market Size Forecast by Regions 13.2 United States 13.3 Europe 13.4 China 13.5 Japan 13.6 Southeast Asia 13.7 India 13.8 Central & South America 13.9 Market Size Forecast by Product (2018-2025) 13.10 Market Size Forecast by Application (2018-2025) 14 Analyst's Viewpoints/Conclusions 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.1.1 Research Programs/Design 15.1.1.2 Market Size Estimation 12.1.1.3 Market Breakdown and Data Triangulation 15.1.2 Data Source 15.1.2.1 Secondary Sources 15.1.2.2 Primary Sources 15.2 Disclaimer 15.3 Author Details
List of Tables and Figures Table Glioblastoma Multiforme Treatment Key Market Segments Table Key Players Glioblastoma Multiforme Treatment Covered Table Global Glioblastoma Multiforme Treatment Market Size Growth Rate by Type 2013-2025 (Million US$) Figure Global Glioblastoma Multiforme Treatment Market Size Market Share by Type 2013-2025 Figure Bevacizumab (Avastin) Figures Table Key Players of Bevacizumab (Avastin) Figure Carmustine (BiCNU) Figures Table Key Players of Carmustine (BiCNU) Figure Temozolomide (Temodar and Temodal and Temcad) Figures Table Key Players of Temozolomide (Temodar and Temodal and Temcad) Table Global Glioblastoma Multiforme Treatment Market Size Growth by Application 2013-2025 (Million US$) Figure Hospital Case Studies Figure Clinic Case Studies Figure Others Case Studies Figure Glioblastoma Multiforme Treatment Report Years Considered Table Global Glioblastoma Multiforme Treatment Market Size 2013-2025 (Million US$) Figure Global Glioblastoma Multiforme Treatment Market Size and Growth Rate 2013-2025 (Million US$) Table Global Glioblastoma Multiforme Treatment Market Size by Regions 2013-2025 (Million US$) Table Global Glioblastoma Multiforme Treatment Market Size by Regions 2013-2018 (Million US$) Table Global Glioblastoma Multiforme Treatment Market Share by Regions 2013-2018 Figure Global Glioblastoma Multiforme Treatment Market Share by Regions 2013-2018 Figure Global Glioblastoma Multiforme Treatment Market Share by Regions 2018 Table Market Top Trends Table Global Glioblastoma Multiforme Treatment Revenue by Manufacturers (2013-2018) (Million US$) Table Global Glioblastoma Multiforme Treatment Market Share by Manufacturers (2013-2018) Figure Global Glioblastoma Multiforme Treatment Market Share by Manufacturers in 2018 Table Global Glioblastoma Multiforme Treatment Manufacturers Market Concentration Ratio (CR5 and HHI) Table Key Players Head office and Area Served Table Key Players Glioblastoma Multiforme Treatment Product/Solution/Service Table Date of Enter into Glioblastoma Multiforme Treatment Market Table Mergers & Acquisitions, Expansion Plans Table Global Glioblastoma Multiforme Treatment Market Size by Type (2013-2018) (Million US$) Table Global Glioblastoma Multiforme Treatment Market Size Share by Type (2013-2018) Figure Global Glioblastoma Multiforme Treatment Market Size Market Share by Type (2013-2018) Table Global Glioblastoma Multiforme Treatment Market Size by Application (2013-2018) (Million US$) Table Global Glioblastoma Multiforme Treatment Market Size Share by Application (2013-2018) Figure Global Glioblastoma Multiforme Treatment Market Size Market Share by Application (2013-2018) Figure Global Glioblastoma Multiforme Treatment Revenue Market Share by Application in 2017 Figure United States Glioblastoma Multiforme Treatment Market Size 2013-2018 (Million US$) Table United States Key Players Glioblastoma Multiforme Treatment Revenue (2017-2018) (Million US$) Table United States Key Players Glioblastoma Multiforme Treatment Market Share (2017-2018) Table United States Glioblastoma Multiforme Treatment Market Size by Type (2013-2018) (Million US$) Table United States Glioblastoma Multiforme Treatment Market Share by Type (2013-2018) Table United States Glioblastoma Multiforme Treatment Market Size by Application (2013-2018) (Million US$) Table United States Glioblastoma Multiforme Treatment Market Share by Application (2013-2018) Figure Europe Glioblastoma Multiforme Treatment Market Size 2013-2018 (Million US$) Table Europe Key Players Glioblastoma Multiforme Treatment Revenue (2017-2018) (Million US$) Table Europe Key Players Glioblastoma Multiforme Treatment Market Share (2017-2018) Table Europe Glioblastoma Multiforme Treatment Market Size by Type (2013-2018) (Million US$) Table Europe Glioblastoma Multiforme Treatment Market Share by Type (2013-2018) Table Europe Glioblastoma Multiforme Treatment Market Size by Application (2013-2018) (Million US$) Table Europe Glioblastoma Multiforme Treatment Market Share by Application (2013-2018) Figure China Glioblastoma Multiforme Treatment Market Size 2013-2018 (Million US$) Table China Key Players Glioblastoma Multiforme Treatment Revenue (2017-2018) (Million US$) Table China Key Players Glioblastoma Multiforme Treatment Market Share (2017-2018) Table China Glioblastoma Multiforme Treatment Market Size by Type (2013-2018) (Million US$) Table China Glioblastoma Multiforme Treatment Market Share by Type (2013-2018) Table China Glioblastoma Multiforme Treatment Market Size by Application (2013-2018) (Million US$) Table China Glioblastoma Multiforme Treatment Market Share by Application (2013-2018) Figure Japan Glioblastoma Multiforme Treatment Market Size 2013-2018 (Million US$) Table Japan Key Players Glioblastoma Multiforme Treatment Revenue (2017-2018) (Million US$) Table Japan Key Players Glioblastoma Multiforme Treatment Market Share (2017-2018) Table Japan Glioblastoma Multiforme Treatment Market Size by Type (2013-2018) (Million US$) Table Japan Glioblastoma Multiforme Treatment Market Share by Type (2013-2018) Table Japan Glioblastoma Multiforme Treatment Market Size by Application (2013-2018) (Million US$) Table Japan Glioblastoma Multiforme Treatment Market Share by Application (2013-2018) Figure Southeast Asia Glioblastoma Multiforme Treatment Market Size 2013-2018 (Million US$) Table Southeast Asia Key Players Glioblastoma Multiforme Treatment Revenue (2017-2018) (Million US$) Table Southeast Asia Key Players Glioblastoma Multiforme Treatment Market Share (2017-2018) Table Southeast Asia Glioblastoma Multiforme Treatment Market Size by Type (2013-2018) (Million US$) Table Southeast Asia Glioblastoma Multiforme Treatment Market Share by Type (2013-2018) Table Southeast Asia Glioblastoma Multiforme Treatment Market Size by Application (2013-2018) (Million US$) Table Southeast Asia Glioblastoma Multiforme Treatment Market Share by Application (2013-2018) Figure India Glioblastoma Multiforme Treatment Market Size 2013-2018 (Million US$) Table India Key Players Glioblastoma Multiforme Treatment Revenue (2017-2018) (Million US$) Table India Key Players Glioblastoma Multiforme Treatment Market Share (2017-2018) Table India Glioblastoma Multiforme Treatment Market Size by Type (2013-2018) (Million US$) Table India Glioblastoma Multiforme Treatment Market Share by Type (2013-2018) Table India Glioblastoma Multiforme Treatment Market Size by Application (2013-2018) (Million US$) Table India Glioblastoma Multiforme Treatment Market Share by Application (2013-2018) Figure Central & South America Glioblastoma Multiforme Treatment Market Size 2013-2018 (Million US$) Table Central & South America Key Players Glioblastoma Multiforme Treatment Revenue (2017-2018) (Million US$) Table Central & South America Key Players Glioblastoma Multiforme Treatment Market Share (2017-2018) Table Central & South America Glioblastoma Multiforme Treatment Market Size by Type (2013-2018) (Million US$) Table Central & South America Glioblastoma Multiforme Treatment Market Share by Type (2013-2018) Table Central & South America Glioblastoma Multiforme Treatment Market Size by Application (2013-2018) (Million US$) Table Central & South America Glioblastoma Multiforme Treatment Market Share by Application (2013-2018) Table AbbVie, Inc Company Details Table AbbVie, Inc Revenue in Glioblastoma Multiforme Treatment Business (2013-2018) (Million US$) Figure AbbVie, Inc Revenue Growth Rate in Glioblastoma Multiforme Treatment Business (2013-2018) Table AbbVie, Inc Recent Development Table Activartis GmbH Company Details Table Activartis GmbH Revenue in Glioblastoma Multiforme Treatment Business (2013-2018)(Million US$) Figure Activartis GmbH Revenue Growth Rate in Glioblastoma Multiforme Treatment Business (2013-2018) Table Activartis GmbH Recent Development Table Agenus Inc Company Details Table Agenus Inc Revenue in Glioblastoma Multiforme Treatment Business (2013-2018)(Million US$) Figure Agenus Inc Revenue Growth Rate in Glioblastoma Multiforme Treatment Business (2013-2018) Table Agenus Inc Recent Development Table Arog Pharmaceuticals, Inc Company Details Table Arog Pharmaceuticals, Inc Revenue in Glioblastoma Multiforme Treatment Business (2013-2018)(Million US$) Figure Arog Pharmaceuticals, Inc Revenue Growth Rate in Glioblastoma Multiforme Treatment Business (2013-2018) Table Arog Pharmaceuticals, Inc Recent Development Table Bristol-Myers Squibb Company Company Details Table Bristol-Myers Squibb Company Revenue in Glioblastoma Multiforme Treatment Business (2013-2018)(Million US$) Figure Bristol-Myers Squibb Company Revenue Growth Rate in Glioblastoma Multiforme Treatment Business (2013-2018) Table Bristol-Myers Squibb Company Recent Development Table Cavion LLC Company Details Table Cavion LLC Revenue in Glioblastoma Multiforme Treatment Business (2013-2018)(Million US$) Figure Cavion LLC Revenue Growth Rate in Glioblastoma Multiforme Treatment Business (2013-2018) Table Cavion LLC Recent Development Table Celldex Therapeutics Inc Company Details Table Celldex Therapeutics Inc Revenue in Glioblastoma Multiforme Treatment Business (2013-2018)(Million US$) Figure Celldex Therapeutics Inc Revenue Growth Rate in Glioblastoma Multiforme Treatment Business (2013-2018) Table Celldex Therapeutics Inc Recent Development Table Cortice Biosciences Company Details Table Cortice Biosciences Revenue in Glioblastoma Multiforme Treatment Business (2013-2018)(Million US$) Figure Cortice Biosciences Revenue Growth Rate in Glioblastoma Multiforme Treatment Business (2013-2018) Table Cortice Biosciences Recent Development Table Exelixis Inc Company Details Table Exelixis Inc Revenue in Glioblastoma Multiforme Treatment Business (2013-2018)(Million US$) Figure Exelixis Inc Revenue Growth Rate in Glioblastoma Multiforme Treatment Business (2013-2018) Table Exelixis Inc Recent Development Table F. Hoffmann-La Roche Ltd. Company Details Table F. Hoffmann-La Roche Ltd. Revenue in Glioblastoma Multiforme Treatment Business (2013-2018)(Million US$) Figure F. Hoffmann-La Roche Ltd. Revenue Growth Rate in Glioblastoma Multiforme Treatment Business (2013-2018) Table F. Hoffmann-La Roche Ltd. Recent Development Table Global Glioblastoma Multiforme Treatment Market Size by Regions (Million US$) 2018-2025 Figure Global Glioblastoma Multiforme Treatment Market Size Share by Regions (2018-2025) Figure Global Glioblastoma Multiforme Treatment Market Size Share by Regions in 2025 Figure United States Glioblastoma Multiforme Treatment Market Size Forecast (2018-2025)(Million USD) Figure Europe Glioblastoma Multiforme Treatment Market Size Forecast (2018-2025)(Million USD) Figure China Glioblastoma Multiforme Treatment Market Size Forecast (2018-2025)(Million USD) Figure Japan Glioblastoma Multiforme Treatment Market Size Forecast (2018-2025)(Million USD) Figure Southeast Asia Glioblastoma Multiforme Treatment Market Size Forecast (2018-2025)(Million USD) Figure India Glioblastoma Multiforme Treatment Market Size Forecast (2018-2025)(Million USD) Figure Central & South America Glioblastoma Multiforme Treatment Market Size Forecast (2018-2025)(Million USD) Table Global Glioblastoma Multiforme Treatment Market Size by Product (2018-2025) (Million US$) Figure Global Glioblastoma Multiforme Treatment Market Size by Product (2018-2025) Figure Global Glioblastoma Multiforme Treatment Market Size by Product in 2025 Table Global Glioblastoma Multiforme Treatment Market Size by Application (2018-2025) (Million US$) Figure Global Glioblastoma Multiforme Treatment Market Size by Application (2018-2025) Figure Global Glioblastoma Multiforme Treatment Market Size by Application in 2025 Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.